Indicators of the functions of the hepatobiliary system in patients with chronic opisthrochisis with the presence of genetic polymorphisms associated with a presposition to the development of osteoporosis
https://doi.org/10.33092/0025-8326mp2025.3.29-35
Abstract
To assess the influence of genetic features of metabolic processes in bone tissue on the reactivity of the hepatobiliary system in opisthorchiasis invasion, a study of biochemical parameters was conducted in subgroups of patients with chronic opisthorchiasis with and without mutations in loci associated with a predisposition to the development of osteoporosis. It was found that the presence of a mutation in the rs1544410 locus of the VDR gene enhances the negative impact of chronic opisthorchiasis invasion on bile secretion (increased alkaline phosphatase activity), and in the rs2234693 locus of the ESR1 gene – on the concentration of glucose in the blood. However, the presence of rare alleles associated with a predisposition to osteoporosis in other loci prevents the negative impact of chronic opisthorchiasis on the functions of the hepatobiliary system and pancreas, namely, an increase in the concentration of bilirubin (ESR1 rs2234693, ESR1 rs9340799), activity of AM (ESR1 rs9340799), ALT (LCT rs4988235), GGT and ALP (LCT rs4988235, LRP5 rs3736228). In the group with a mutation in the rs1800012 locus of the COL1 A1 gene, differences in the change in indicators (ALT, AST and GGT activity) after anthelmintic therapy were revealed, possibly associated with the role of collagen in the reaction of metabolic processes not only to invasion, but also to the treatment process.
About the Authors
I. V. BakshtanovskayaRussian Federation
K. B. Stepanova
Russian Federation
T. F. Stepanova
Russian Federation
A. N. Ozerova
Russian Federation
E. A. Zmatrakova
Russian Federation
References
1. Bakshtanovskaya I.V., Stepanova K.B., Ozerova A.N., Stepanova T.F., Zmatrakova E.A. Indicators of hepatobiliary system functions in patients with chronic opisthorchiasis with a genetic predisposition to the development of type 2 diabetes mellitus. Medical parasitology and parasitic diseases. 2023; 1:3-9. in Russian Doi:10.33092/0025-8326mp2023.1.3-9.
2. Bakshtanovskaya I.V., Stepanova K.B., Ozerova A.N., Stepanova T.F., Zmatrakova E.A. Indicators of hepatobiliary system functions in patients with chronic opisthorchiasis with a genetic predisposition to lipid metabolism disorders. Med parazitol (Mosk). 2023; 4:22-29. in Russian Doi: 10.33092/0025-8326mp2023.4.22-29
3. Stepanova T.F. Opisthorchiasis: new views on the invasive disease, the basics of clinical rehabilitation, the methodology of large-scale recreational work. Tyumen.2002. p.196 in Russian
4. Bakshtanovskaya I.V., Stepanova K.B., Kal’gina G.A., Stepanova T.F. Relationships between biochemical and immunological parameters in patients with chronic opisthorchiasis. Med parazitol (Mosk). 2018; 2:13-19.in Russian
5. Baykova O.A., Nikolaeva N.N., Grishchenko E.G., Nikolaeva L.V. Opisthorchiasis and clonorchiasis treatment: modern approach, concerns and perspectives. The Journal of scientific articles “Health and Education Millennium”, 2017. Vol. 19. No 6. Р.14-25 in Russian
6. Grigorieva I.N. Opisthorchiasis: traditions and innovations. Experimental and clinical gastroenterology. 2012. No 4. P.54-59 in Russian
7. Mailyan E.A. Multifactorial pathogenesis of osteoporosis and the role of genes of canonical WNT-signaling pathway. Osteoporosis and Bone Diseases. 2015;18(2):15-19. in Russian doi: 10.14341/osteo2015215-19
8. Zhong B., Huang D., Ma K., Deng X., Shi D., Wu F., Shao Z. Association of COL1A1 rs1800012 polymorphism with musculoskeletal degenerative diseases: a metaanalysis. Oncotarget,2017.8(43),75488–75499. doi:10.18632/oncotarget.20797
9. Kong M., Xiang B. Identifying biomarkers to predict the prognosis of biliary atresia by weighted gene co-expression network analysis. Frontiers in genetics, 2021. 12, 760182. doi:10.3389/fgene.2021.760182
10. Ceci L., Gaudio E., Kennedy L. Cellular interactions and crosstalk facilitating biliary fibrosis in cholestasis. Cellular and molecular gastroenterology and hepatology, 2024. 17(4), 553–565. doi:10.1016/j.jcmgh.2024.01.005
11. Vlashi R., Zhang X., Wu M., Chen G. Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders. Genes Dis. 2022; 10(4): 1291-1317. doi:10.1016/j.gendis.2022.07.011
12. Singh S., Budiman T., Redmond D., Gupta V. Modulation of canonical Wnt signaling regulates peribiliary mesenchymal identity during homeostasis and injury. Hepatol Commun. 2024;8(2):e0368. doi:10.1097/HC9.0000000000000368
13. Han D., Zhang H., Liu S., Zhuang L., Zhao Z., Ding H., Xin Y. Association between the LRP5 rs556442 gene polymorphism and the risks of NAFLD and CHD in a Chinese Han population. BMC gastroenterology, 2022. 22(1), 305. doi:10.1186/s12876-022-02385-9
14. Norcia L.F., Watanabe E.M., Hamamoto Filho P.T., Hasimoto C.N., Pelafsky L., de Oliveira W.K., Sassaki L.Y. Polycystic liver disease: pathophysiology, diagnosis and treatment. Hepatic medicine: evidence and research, 2022. 14, 135–161. doi:10.2147/HMER.S377530
15. Kowalówka M., Kosewski G., Lipiński D., Przysławski J. A comprehensive look at the -13910 C>T LCT gene polymorphism as a molecular marker for vitamin D and calcium levels in young adults in central and eastern europe: a preliminary study. Int J Mol Sci. 2023;24(12):10191. doi:10.3390/ijms241210191
16. Tanpowpong P., Aekplakorn W., Chariyalertsak S., et al. Higher milk consumption is associated with a lower risk of diabetes mellitus: A case-control study. PLoS One. 2023;18(8):e0289762. doi:10.1371/journal.pone.0289762
17. Thanapirom K., Suksawatamnuay S., Sukeepaisarnjaroen W., Tangkijvanich P., Thaimai P., Wasitthankasem R., Poovorawan Y., Komolmit P. Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C. PeerJ, 2019. 7, e7666. https://doi.org/10.7717/peerj.7666
18. Friedrich D.C., de Andrade F.M., Fiegenbaum M., et al. The lactase persistence genotype is a protective factor for the metabolic syndrome. Genet Mol Biol. 2014;37(4):611-615. doi:10.1590/S1415-47572014005000012
19. Kurlaeva L.V., Stepanova T.F., Stepanova K.B., Kosyreva A.N., Bakshtanovskaya I.V., Kalgina G.A., Grigorieva S.A. IImmunological parameters in patients with chronic opisthorchiasis bearing gene mutations associated with osteoporosispredisposition // Russian Journal of Infection and Immunity. 2023. Vol. 13. N. 5. P. 923-930. doi: 10.15789/2220-7619-IPI-8486
Review
For citations:
Bakshtanovskaya I.V., Stepanova K.B., Stepanova T.F., Ozerova A.N., Zmatrakova E.A. Indicators of the functions of the hepatobiliary system in patients with chronic opisthrochisis with the presence of genetic polymorphisms associated with a presposition to the development of osteoporosis. Medical Parasitology and Parasitic Diseases. 2025;(3):29-35. (In Russ.) https://doi.org/10.33092/0025-8326mp2025.3.29-35
JATS XML







